Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

Richard Attack is sharing his prostate cancer story to help raise awareness ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

Throne, a startup based in Austin, has developed a toilet add-on that measures gut health through things like frequency, ...

Chinese assets have outgrown a “bargain basement” label as the upfront value of licensing deals involving them has increased, ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Spoiler alert: You can stop TRT — but the way you do so matters. Stopping abruptly ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 –– Reduced secured and convertible debt by 90% from ...

While the study found that vegetarian diets reduced the risk of five major types of cancer, it also found that vegetarian ...